Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies. Reumatismo [Internet]. 2023 Dec. 19 [cited 2025 Apr. 23];75(4). Available from: https://www.reumatismo.org/reuma/article/view/1602